Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Visceral Adiposity Measurement and Observation Study

NCT05383456 is registered in ClinicalTrials.gov with Theratechnologies as lead sponsor.

NCT NCT05383456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Visceral Adiposity Measurement and Observation Study
Lead sponsor
Theratechnologies
Phase
Observational
Overall status
Completed
Start date
April 18, 2022
Completion date
October 30, 2023
Enrollment
196 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bmi, ectopic fat, hepatic fibrosis, hepatic steatosis, hiv, hiv disease progression, hiv i infection, hiv infection primary, hiv lipodystrophy, hiv-1-infection, hiv-associated lipodystrophy, hiv-infections, lipohypertrophy, liver diseases, liver fat, liver fibrosis, nafld, nash, waist circumference